2026 Global: Catgut Suture Market -Competitive Review (2032) report
Description
The 2026 Global: Catgut Suture Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Major players in the catgut suture market include Ethicon, a Johnson & Johnson subsidiary (Headquarters: New Brunswick, United States), B. Braun Melsungen AG (Headquarters: Melsungen, Germany), Medtronic plc (Covidien) (Headquarters: Dublin, Ireland), and Teleflex Incorporated (Headquarters: Wayne, United States). These firms maintain global supply chains, regulatory approvals, and extensive distribution networks for traditional gut sutures alongside absorbable alternatives. Ethicon offers gut sutures within a natural and synthetic portfolio; B. Braun provides gut-based products; Medtronic’s Covidien span included catgut offerings; Teleflex integrates gut sutures into general suture assemblies. Market dynamics emphasize sterility, consistent absorption timing, and predictable tissue response, since catgut performance is influenced by manufacturing and sterilization. In regions that favor natural sutures for hemostasis, catgut remains in demand, though increasingly as a specialty within larger portfolios. Regulatory scrutiny, quality assurance, and ethical sourcing also shape supplier relationships and pricing, particularly for animal-derived materials. Markets demand consistent traceability and audits.
Additional suppliers of catgut sutures include Kuraray Co., Ltd. (Headquarters: Tokyo, Japan), Gunze Ltd. (Headquarters: Osaka, Japan), DemeTECH Corporation (Headquarters: Miami, United States), and Weigao Group Co., Ltd. (Headquarters: Weihai, China). These firms expand access to gut products through dedicated manufacturing lines. Kuraray, a diversified chemical company, maintains a selective gut suture portfolio aligned with its biopolymer strands and collagen processing capabilities. Gunze leverages its textile and biomedical materials expertise to deliver standardized catgut strands with uniform absorption profiles. DemeTECH markets a range of natural gut sutures and complementary devices, emphasising regulatory compliance and sterility across multi-region supply chains. Weigao Group, one of China's leading medical device groups, integrates gut sutures into its broader portfolio of surgical supplies for domestic and international markets. Collectively, these players emphasize product consistency, sterilization integrity, and scalable production to support hospitals, clinics, and specialty practices that rely on traditional gut sutures in selected procedures.
Sun Medical Co., Ltd. (Headquarters: Moriyama, Japan) and Kanghui Medical Co., Ltd. (Headquarters: Beijing, China) round out the catgut suture producers. Sun Medical leverages its research in animal-derived collagen and enzymatic processing to deliver gut sutures with uniform diameter, predictable absorption, and consistent knot-holding properties across batches. Kanghui Medical, a major Chinese supplier, emphasizes integrated product lines that include natural gut sutures alongside other absorbable options, supporting hospital procurement in East Asia and export markets. In many regions, catgut sutures remain a niche line tailored to specific surgical indications, such as ocular or delicate tissue repair, where rapid absorption and pliability can be advantageous. These two companies illustrate how regional manufacturers continue to preserve animal-derived sutures within broader portfolios, balancing cost, regulatory compliance, and supply chain resilience. For researchers and clinicians, understanding their catalogues helps assess availability, quality control practices, and potential supply risks in the catgut suture market globally.
Major players in the catgut suture market include Ethicon, a Johnson & Johnson subsidiary (Headquarters: New Brunswick, United States), B. Braun Melsungen AG (Headquarters: Melsungen, Germany), Medtronic plc (Covidien) (Headquarters: Dublin, Ireland), and Teleflex Incorporated (Headquarters: Wayne, United States). These firms maintain global supply chains, regulatory approvals, and extensive distribution networks for traditional gut sutures alongside absorbable alternatives. Ethicon offers gut sutures within a natural and synthetic portfolio; B. Braun provides gut-based products; Medtronic’s Covidien span included catgut offerings; Teleflex integrates gut sutures into general suture assemblies. Market dynamics emphasize sterility, consistent absorption timing, and predictable tissue response, since catgut performance is influenced by manufacturing and sterilization. In regions that favor natural sutures for hemostasis, catgut remains in demand, though increasingly as a specialty within larger portfolios. Regulatory scrutiny, quality assurance, and ethical sourcing also shape supplier relationships and pricing, particularly for animal-derived materials. Markets demand consistent traceability and audits.
Additional suppliers of catgut sutures include Kuraray Co., Ltd. (Headquarters: Tokyo, Japan), Gunze Ltd. (Headquarters: Osaka, Japan), DemeTECH Corporation (Headquarters: Miami, United States), and Weigao Group Co., Ltd. (Headquarters: Weihai, China). These firms expand access to gut products through dedicated manufacturing lines. Kuraray, a diversified chemical company, maintains a selective gut suture portfolio aligned with its biopolymer strands and collagen processing capabilities. Gunze leverages its textile and biomedical materials expertise to deliver standardized catgut strands with uniform absorption profiles. DemeTECH markets a range of natural gut sutures and complementary devices, emphasising regulatory compliance and sterility across multi-region supply chains. Weigao Group, one of China's leading medical device groups, integrates gut sutures into its broader portfolio of surgical supplies for domestic and international markets. Collectively, these players emphasize product consistency, sterilization integrity, and scalable production to support hospitals, clinics, and specialty practices that rely on traditional gut sutures in selected procedures.
Sun Medical Co., Ltd. (Headquarters: Moriyama, Japan) and Kanghui Medical Co., Ltd. (Headquarters: Beijing, China) round out the catgut suture producers. Sun Medical leverages its research in animal-derived collagen and enzymatic processing to deliver gut sutures with uniform diameter, predictable absorption, and consistent knot-holding properties across batches. Kanghui Medical, a major Chinese supplier, emphasizes integrated product lines that include natural gut sutures alongside other absorbable options, supporting hospital procurement in East Asia and export markets. In many regions, catgut sutures remain a niche line tailored to specific surgical indications, such as ocular or delicate tissue repair, where rapid absorption and pliability can be advantageous. These two companies illustrate how regional manufacturers continue to preserve animal-derived sutures within broader portfolios, balancing cost, regulatory compliance, and supply chain resilience. For researchers and clinicians, understanding their catalogues helps assess availability, quality control practices, and potential supply risks in the catgut suture market globally.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
